Your browser doesn't support javascript.
loading
Clinical Characteristics, Surgical Outcomes, and Prognostic Factors of Intracranial Primary Central Nervous System Lymphoma.
Ouyang, Taohui; Wang, Long; Zhang, Na; Zhang, Zongyong; Xiong, Yifeng; Li, Meihua; Hong, Tao.
Afiliación
  • Ouyang T; Department of Neurosurgery, the First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
  • Wang L; Department of Neurosurgery, Affiliated Heping Hospital of Chang Zhi Medical College, Changzhi, Shanxi, China.
  • Zhang N; Department of Neurology, the First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China. Electronic address: hustzhangna@163.com.
  • Zhang Z; Department of Neurosurgery, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
  • Xiong Y; Department of Pathology, the First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
  • Li M; Department of Neurosurgery, the First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
  • Hong T; Department of Neurosurgery, the First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
World Neurosurg ; 139: e508-e516, 2020 07.
Article en En | MEDLINE | ID: mdl-32311566
ABSTRACT

BACKGROUND:

Intracranial primary central nervous system lymphoma (PCNSL) is a rare aggressive malignant tumor with poor prognosis. The effect of surgical resection on intracranial PCNSL is still controversial. This study investigates the efficacy and safety of surgical resection, as well as to analyze the clinical characteristics and prognostic factors of intracranial PCNSL.

METHODS:

The clinical materials of 89 consecutive patients with intracranial PCNSL were analyzed retrospectively. Outcome in survival was assessed by progression-free survival (PFS) and overall survival (OS). Univariate and multivariate analyses were performed for various potential prognostic factors to identify independent prognostic factors of intracranial PCNSL.

RESULTS:

Among the 89 patients, gross total resection (GTR) was achieved in 57 patients (64.0%), subtotal resection (STR) in 14 patients (15.8%), and biopsy in 18 patients (20.2%).The PFS and OS at 2 years were estimated at 32.3% and 74.1%, respectively. The median PFS was 20 months (95% confidence interval, 16-23) and the median OS was 32 months (95% confidence interval, 25-38). Patients with surgical resection (GTR and STR) had better PFS than those with biopsy, and the difference of PFS was statistically significant (P = 0.007). However, the difference of OS was not statistically significant (P = 0.062). Multivariate analysis showed that invasion of deep structure was the only independent risk factor for intracranial PCNSL. Eleven patients (12.4%) had surgical complications, mainly including limb weakness and visual field defect.

CONCLUSIONS:

For intracranial PCNSL, surgical excision can improve PFS but not OS. Invasion of deep structure was the only independent risk factor for intracranial PCNSL.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias del Sistema Nervioso Central / Procedimientos Neuroquirúrgicos / Linfoma Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: World Neurosurg Asunto de la revista: NEUROCIRURGIA Año: 2020 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias del Sistema Nervioso Central / Procedimientos Neuroquirúrgicos / Linfoma Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: World Neurosurg Asunto de la revista: NEUROCIRURGIA Año: 2020 Tipo del documento: Article